Factors influencing failure of progression to completion hepatectomy following liver venous deprivation procedures (PVE or DVE): a longitudinal observational study

IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Hpb Pub Date : 2025-03-01 DOI:10.1016/j.hpb.2024.11.011
Swizel A. Cardoso , George Clarke , Ananya Nayak , Kunal Joshi , Ramanivas Sudereyan , Salil Karkhanis , Nikolaos Chatzizacharias , Keith J. Roberts , Naveen Condati , Michail Papamichail , Ravi Marudanayagam , David Bartlett , Syed S. Raza , Robert P. Sutcliffe , Homoyoon Mehrzad , Bobby V.M. Dasari
{"title":"Factors influencing failure of progression to completion hepatectomy following liver venous deprivation procedures (PVE or DVE): a longitudinal observational study","authors":"Swizel A. Cardoso ,&nbsp;George Clarke ,&nbsp;Ananya Nayak ,&nbsp;Kunal Joshi ,&nbsp;Ramanivas Sudereyan ,&nbsp;Salil Karkhanis ,&nbsp;Nikolaos Chatzizacharias ,&nbsp;Keith J. Roberts ,&nbsp;Naveen Condati ,&nbsp;Michail Papamichail ,&nbsp;Ravi Marudanayagam ,&nbsp;David Bartlett ,&nbsp;Syed S. Raza ,&nbsp;Robert P. Sutcliffe ,&nbsp;Homoyoon Mehrzad ,&nbsp;Bobby V.M. Dasari","doi":"10.1016/j.hpb.2024.11.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Two-staged hepatectomy (TSH) with portal (PVE) or dual vein embolization (DVE) gained acceptance in liver surgery. The current study assesses the incidence and causes of failure to progress to completion hepatectomy following PVE/DVE and its influence on overall survival (OS).</div></div><div><h3>Methods</h3><div>This is a longitudinal observational study of patients who underwent PVE or DVE between April 2010–December 2023. Future liver remnant (FLR) volume was measured at least four weeks later. Restaging and resectability was assessed on imaging performed within 6–8 weeks of planned completion surgery.</div></div><div><h3>Results</h3><div>130 patients underwent PVE (90) or DVE (40) during the study period. Of these, 73 (56 %) patients proceeded to definitive resection. Reasons for failure to progress to completion surgery were: disease progression (79 %), declined fitness for surgery (3.5 %) and inadequate FLR volume (14 %). Synchronous disease is a poor prognostic factor for achieving completion hepatectomy CRLM patients (p = 0.009). The median OS with and without completion hepatectomy was 38 months vs. 13 months in CRLM patients (p=&lt;.001) and 31 months vs. 26 months in pCCA groups respectively (p = 0.471).</div></div><div><h3>Conclusion</h3><div>A significant percentage of patients did not progress to completion hepatectomy due to disease progression. Patient selection and efficient pathways are essential to improve resection rates following these resource-intensive procedures.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 3","pages":"Pages 299-310"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hpb","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1365182X24024262","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Two-staged hepatectomy (TSH) with portal (PVE) or dual vein embolization (DVE) gained acceptance in liver surgery. The current study assesses the incidence and causes of failure to progress to completion hepatectomy following PVE/DVE and its influence on overall survival (OS).

Methods

This is a longitudinal observational study of patients who underwent PVE or DVE between April 2010–December 2023. Future liver remnant (FLR) volume was measured at least four weeks later. Restaging and resectability was assessed on imaging performed within 6–8 weeks of planned completion surgery.

Results

130 patients underwent PVE (90) or DVE (40) during the study period. Of these, 73 (56 %) patients proceeded to definitive resection. Reasons for failure to progress to completion surgery were: disease progression (79 %), declined fitness for surgery (3.5 %) and inadequate FLR volume (14 %). Synchronous disease is a poor prognostic factor for achieving completion hepatectomy CRLM patients (p = 0.009). The median OS with and without completion hepatectomy was 38 months vs. 13 months in CRLM patients (p=<.001) and 31 months vs. 26 months in pCCA groups respectively (p = 0.471).

Conclusion

A significant percentage of patients did not progress to completion hepatectomy due to disease progression. Patient selection and efficient pathways are essential to improve resection rates following these resource-intensive procedures.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
影响肝静脉剥夺手术(PVE或DVE)后肝切除术进展失败的因素:一项纵向观察研究。
背景:两阶段肝切除术(TSH)联合门静脉(PVE)或双静脉栓塞(DVE)在肝脏手术中得到认可。目前的研究评估了PVE/DVE术后未能完成肝切除术的发生率和原因及其对总生存率(OS)的影响。方法:这是一项纵向观察研究,研究对象是2010年4月至2023年12月期间接受PVE或DVE治疗的患者。至少4周后测量未来肝残体(FLR)体积。在计划完成手术的6-8周内通过影像学评估再固定和可切除性。结果:130例患者在研究期间接受了PVE(90例)或DVE(40例)。其中,73例(56%)患者进行了最终切除。未能进展到完成手术的原因是:疾病进展(79%),手术适应度下降(3.5%)和FLR容量不足(14%)。同步疾病是实现完全肝切除术的CRLM患者预后不良的因素(p = 0.009)。有和没有完成肝切除术的CRLM患者的中位总生存期分别为38个月和13个月(p=结论:由于疾病进展,有很大比例的患者没有完成肝切除术。患者选择和有效的途径是提高这些资源密集型手术后的切除率必不可少的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hpb
Hpb GASTROENTEROLOGY & HEPATOLOGY-SURGERY
CiteScore
5.60
自引率
3.40%
发文量
244
审稿时长
57 days
期刊介绍: HPB is an international forum for clinical, scientific and educational communication. Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice. Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice. HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields. Abstracted and Indexed in: MEDLINE® EMBASE PubMed Science Citation Index Expanded Academic Search (EBSCO) HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).
期刊最新文献
Conference Calendar Contents Percutaneous hepatic artery infusion chemotherapy with oxaliplatin and fluoropyrimidines in treatment-resistant colorectal cancer patients with unresectable liver metastases: a retrospective cohort study ChatGPT vs. surgeons on pancreatic cancer queries: accuracy & empathy evaluated by patients and experts Utility of endoscopic ultrasound-guided fine needle aspiration for genetic analysis in pancreatic ductal adenocarcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1